ICER, CADTH, and NICE collaborate to increase t...

By Staff Writer

May 2, 2023

The Institute for Clinical and Economic Review (ICER), the Canadian Agency for Drugs and Technologies in Health (CADTH), and the UK’s National Institute for Health and Care Excellence (NICE) have announced changes to the way confidential informati...
ICER Report on Lecanemab: Efficacy, Cost, and Equity Concerns for Alzheimer&#...
New Preferred Characteristics for Monoclonal Antibodies in Malaria Prevention
Tezepelumab as an Add-on Maintenance Treatment for Severe Asthma: Recommendat...
Quantitative Benefit-Risk Assessment in Medical Product Decision Making: A Go...
Zambia’s National Health Insurance Making Progress Towards Strategic Pu...
Chronic Heart Failure: PBAC Recommends Empagliflozin
Global Pull Incentive Needed to Future-Proof Antibiotic Innovation, Says OHE ...
Genedrive MT-RNR1 ID Kit to detect genetic variation and protect hearing in b...
Abu Dhabi Recognises Abu Dhabi Stem Cells Center (ADSCC) as a Centre of Excel...
Did CVDs recover post COVID-19 ?
Multiple myeloma is the second most common type of blood cancer, with approxi...
The evidence for Cannabidiol is building